More than a decade after it was first proposed, the U.S. Precision Medicine Initiative that grew into the NIH’s All of Us dataset has reached its target of collecting genetic and health-related data from 1 million Americans representative of the diversity across the country.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Encora, Inmune, Novocure, Serac, Teijin.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Aardvark, Alkermes, Avadel, Cellprothera, Celyad, Centessa, Eradivir, I-sens, Lifescan, Natus, Nxera, Onconetix, Realbotix, Seres, Therab.
Clinical updates for biopharma and med tech, including data readouts and publications: Annovis, Biovica, Brainscope, Bridgebio, Caredx, Immunesensor, Mesoblast, Surge.
Biopharma and med-tech companies raising money in public or private financings, including: Berlin Heals, Biorestorative, Entirety, Nektar, Neupulse, Neurent, Xilio.
Agios Pharmaceuticals Inc. is preparing to present a mixed bag of phase III Rise Up data to the U.S. FDA in hopes of “full approval” for mitapivat in sickle cell disease (SCD), which would make it its third indication in rare hematology.
RSS